US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
Here's what Google's new finance chief will need to do to keep investors happy
Morgan Stanley laid out a to-do list for Google's new finance chief. Here's what they want.
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also 'on notice'
The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...
Weight-loss meds get a markdown
Discounts of as much as half on the $1,000-plus-a-month injectables are meant to induce insurers to offer coverage to workers ...
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...